These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 19192442

  • 1. Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis.
    Bond DJ, Noronha MM, Kauer-Sant'Anna M, Lam RW, Yatham LN.
    J Clin Psychiatry; 2008 Oct; 69(10):1589-601. PubMed ID: 19192442
    [Abstract] [Full Text] [Related]

  • 2. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
    Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM.
    Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
    Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI.
    J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
    [Abstract] [Full Text] [Related]

  • 4. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS, Benazzi F, Perugi G, Rihmer Z.
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [Abstract] [Full Text] [Related]

  • 5. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
    Papakostas GI, Martinson MA, Fava M, Iovieno N.
    J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
    [Abstract] [Full Text] [Related]

  • 6. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L.
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, Coghill D, Zhang Y, Hazell P, Leucht S, Cuijpers P, Pu J, Cohen D, Ravindran AV, Liu Y, Michael KD, Yang L, Liu L, Xie P.
    Lancet; 2016 Aug 27; 388(10047):881-90. PubMed ID: 27289172
    [Abstract] [Full Text] [Related]

  • 8. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct 27; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

  • 9. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH.
    J Clin Psychiatry; 2013 Nov 27; 74(11):1101-7. PubMed ID: 24330897
    [Abstract] [Full Text] [Related]

  • 10. Bipolar depression and antidepressant-induced mania: a naturalistic study.
    Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL.
    J Clin Psychiatry; 1998 Jul 27; 59(7):374-9. PubMed ID: 9714266
    [Abstract] [Full Text] [Related]

  • 11. Antidepressant-induced hypomania/mania in patients with major depression: Evidence from the BRIDGE-II-MIX study.
    Barbuti M, Pacchiarotti I, Vieta E, Azorin JM, Angst J, Bowden CL, Mosolov S, Young AH, Perugi G, BRIDGE-II-Mix Study Group.
    J Affect Disord; 2017 Sep 27; 219():187-192. PubMed ID: 28558366
    [Abstract] [Full Text] [Related]

  • 12. Comparison of associated features and drug treatment between co-occurring unipolar and bipolar disorders in depressed eating disorder patients.
    Tseng MM, Chang CH, Liao SC, Chen HC.
    BMC Psychiatry; 2017 Feb 27; 17(1):81. PubMed ID: 28241886
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis.
    Ma D, Zhang Z, Zhang X, Li L.
    Curr Med Res Opin; 2014 Jun 27; 30(6):971-95. PubMed ID: 24188102
    [Abstract] [Full Text] [Related]

  • 14. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
    Amsterdam JD, Lorenzo-Luaces L, Soeller I, Li SQ, Mao JJ, DeRubeis RJ.
    J Affect Disord; 2015 Oct 01; 185():31-7. PubMed ID: 26143402
    [Abstract] [Full Text] [Related]

  • 15. Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial.
    Jha MK, Malchow AL, Grannemann BD, Rush AJ, Trivedi MH.
    Neuropsychopharmacology; 2018 Oct 01; 43(11):2197-2203. PubMed ID: 30135556
    [Abstract] [Full Text] [Related]

  • 16. A prediction rule for diagnosing hypomania.
    Benazzi F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):317-22. PubMed ID: 19141309
    [Abstract] [Full Text] [Related]

  • 17. Antidepressant-induced mood conversions in bipolar disorder: a retrospective study of tricyclic versus non-tricyclic antidepressant drugs.
    Koszewska I, Rybakowski JK.
    Neuropsychobiology; 2009 Mar 17; 59(1):12-6. PubMed ID: 19221443
    [Abstract] [Full Text] [Related]

  • 18. Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review.
    Baldessarini RJ, Faedda GL, Offidani E, Vázquez GH, Marangoni C, Serra G, Tondo L.
    J Affect Disord; 2013 May 15; 148(1):129-35. PubMed ID: 23219059
    [Abstract] [Full Text] [Related]

  • 19. Treating mixed mania/hypomania: a review and synthesis of the evidence.
    Takeshima M.
    CNS Spectr; 2017 Apr 15; 22(2):177-185. PubMed ID: 28004626
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR.
    Lancet; 2018 Apr 07; 391(10128):1357-1366. PubMed ID: 29477251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.